Plain-English translation of NCT03517579 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Radioactive iodine (I-131) has been used successfully to treat thyroid disease for decades, but doctors currently estimate doses using outdated methods that can lead to treatment failures or unwanted side effects. This pilot study is testing a novel wearable radiation detector worn around the neck to measure how the body handles the radioactive iodine more accurately over several days. The goal is to help doctors tailor future treatment doses more precisely to each patient's needs.
Current dosing methods for radioactive iodine treatment use measurements taken at only one or two time points, which often results in either underdosing (failure to cure the disease) or overdosing (causing unnecessary side effects like dry mouth and swelling). This research aims to solve that problem by using continuous monitoring technology to guide better, more personalized treatment decisions.
You likely qualify if…
You likely don't qualify if…
You will receive a standard radioactive iodine treatment dose calculated using conventional methods. During the study, you will wear a special collar-like radiation detection device around your neck for several days following your treatment to continuously measure how the radioactive iodine is being taken up by your body. This pilot study involves 10 patients total and is designed to gather information that may help improve dosing methods for future patients.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States